The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


VIZARSIN

50 Milligram Orodispersible Tablet

Krka d.d., Novo mestoEU/1/09/551/018-022

Main Information

Trade NameVIZARSIN
Active SubstancesSILDENAFIL
Strength50 Milligram
Dosage FormOrodispersible Tablet
Licence HolderKrka d.d., Novo mesto
Licence NumberEU/1/09/551/018-022

Group Information

ATC CodeG04BE03 sildenafil

Status

Authorised/WithdrawnAuthorised
Licence Issued15/05/2012
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing Status

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable List CodeIC0063-023-004
Interchangeable List DocumentPDF of Interchangeable List
« Back